Influence of osteoprotegerin on differentiation, activation, and apoptosis of gaoyou duck embryo osteoclasts in vitro

Poultry Science

Volumn 92, Issue 6, 2013, Pages 1613-1620

  Fu, Ying Xiao ^a   Gu, Jian Hong ^a   Zhang, Yi Ran ^a   Tong, Xi Shuai ^a   Zhao, Hong Yan ^a   Yuan, Yan ^a   Liu, Xue Zhong ^a   Bian, Jian Chun ^a   Liu, Zong Ping ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Activation; Apoptosis; Differentiation; Gaoyou duck embryo osteoclast; Osteoprotegerin

Indexed keywords

EID: 84877943649     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2012-02756     Document Type: Article

References (38)

1. Akatsu, T., T. Murakami, M. Nishikawa, K. Ono, N. Shinomiya, E. Tsuda, S. Mochizuki, K. Yamaguchi, M. Kinosaki, K. Higashio, M. Yamamoto, K. Motoyoshi, and N. Nagata. 1998. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem. Biophys. Res. Commun. 250:229-234.
2. Aldridge, S. E., T. W. Lennard, J. R. Williams, and M. A. Birch. 2005. Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 335:793-798.
3. Arnett, T. R., and D. W. Dempster. 1987. A comparative study of disaggregated chick and rat osteoclasts in vitro: Effects of calcitonin and prostaglandins. Endocrinology 120:602-608.
4. Boyce, B. F., and L. Xing. 2007. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 9(Suppl. 1):S1.
5. Boyce, B. F., and L. Xing. 2008. Functions of RANKL/RANK/ OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473:139-146.
6. Chambers, T. J., and C. L. Magnus. 1982. Calcitonin alters behaviour of isolated osteoclasts. J. Pathol. 136:27-39.
7. Choi, H. J., Y. R. Park, M. Nepal, B. Y. Choi, N. P. Cho, S. H. Choi, S. R. Heo, H. S. Kim, M. S. Yang, and Y. Soh. 2010. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways. Eur. J. Pharmacol. 636:28-35.
8. Clezardin, P. 2011. The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: Physiopathology and clinical implications. Bull. Cancer 98:837-846.
9. Gay, C. V. 1991. Avian osteoclasts. Calcif. Tissue Int. 49:153-154.
10. Gu, J. H., J. D. Liu, Y. Shen, and Z. P. Liu. 2009. Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. Vet. J. 181:321-325.
11. Henriksen, K., J. Bollerslev, V. Everts, and M. A. Karsdal. 2011. Osteoclast activity and subtypes as a function of physiology and pathology-Implications for future treatments of osteoporosis. Endocr. Rev. 32:31-63.
12. Hofbauer, L. C., C. A. Kuhne, and V. Viereck. 2004. The OPG/ RANKL/RANK system in metabolic bone diseases. J. Musculoskelet. Neuronal Interact. 4:268-275.
13. Hotokezaka, H., E. Sakai, K. Kanaoka, K. Saito, K. Matsuo, H. Kitaura, N. Yoshida, and K. Nakayama. 2002. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J. Biol. Chem. 277:47366-47372.
14. Huang, J., L. Yuan, X. Wang, T. L. Zhang, and K. Wang. 2007. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci. 81:832-840.
15. Hughes, D. E., and B. F. Boyce. 1997. Apoptosis in bone physiology and disease. Mol. Pathol. 50:132-137.
16. Hughes, D. E., K. R. Wright, H. L. Uy, A. Sasaki, T. Yoneda, G. D. Roodman, G. R. Mundy, and B. F. Boyce. 1995. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 10:1478-1487.
17. Jansen, I. D., J. A. Vermeer, V. Bloemen, J. Stap, and V. Everts. 2012. Osteoclast fusion and fission. Calcif. Tissue Int. 90:515- 522.
18. Jones, S. J., N. N. Ali, and A. Boyde. 1986. Survival and resorptive activity of chick osteoclasts in culture. Anat. Embryol. (Berl.) 174:265-275.
19. Kim, T., H. Ha, N. Kim, E. S. Park, J. Rho, E. C. Kim, J. Lorenzo, Y. Choi, and S. H. Lee. 2010. ATP6v0d2 deficiency increases bone mass, but does not influence ovariectomy-induced bone loss. Biochem. Biophys. Res. Commun. 403:73-78.
20. Kobayashi, Y., F. Hashimoto, H. Miyamoto, K. Kanaoka, Y. Miyazaki-Kawashita, T. Nakashima, M. Shibata, K. Kobayashi, Y. Kato, and H. Sakai. 2000. Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression. J. Bone Miner. Res. 15:1924-1934.
21. Lion, J. M., R. Mentaverri, S. Rossard, N. Jullian, B. Courtois, J. Courtois, M. Brazier, J. C. Maziere, and S. Kamel. 2009. Oligogalacturonic acid inhibit bone resorption and collagen degradation through its interaction with type I collagen. Biochem. Pharmacol. 78:1448-1455.
22. Mukherjee, A., and P. Rotwein. 2012. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mol. Cell. Biol. 32:490-500.
23. Nakamura, I., N. Takahashi, E. Jimi, N. Udagawa, and T. Suda. 2012. Regulation of osteoclast function. Mod. Rheumatol. 22:167-177.
24. Rath, N. C., J. M. Balog, W. E. Huff, G. R. Huff, G. B. Kulkarni, and J. F. Tierce. 1999. Comparative differences in the composition and biomechanical properties of tibiae of seven- and seventytwo-week-old male and female broiler breeder chickens. Poult. Sci. 78:1232-1239.
25. Rath, N. C., G. R. Huff, W. E. Huff, and J. M. Balog. 2000. Factors regulating bone maturity and strength in poultry. Poult. Sci. 79:1024-1032.
26. Roodman, G. D. 1999. Cell biology of the osteoclast. Exp. Hematol. 27:1229-1241.
27. Sahin, K., M. Onderci, N. Sahin, T. A. Balci, M. F. Gursu, V. Juturu, and O. Kucuk. 2006. Dietary arginine silicate inositol complex improves bone mineralization in quail. Poult. Sci. 85:486-492.
28. Sanchez-Fernandez, M. A. A. G., R. Thilo, J. Pierre, and H. Bernard. 2008. Osteoclasts control osteoblast chemotaxis via PDGF--BB/PDGF receptor beta signaling. PLoS ONE 3:e3537.
29. Santini, D., G. Schiavon, B. Vincenzi, L. Gaeta, F. Pantano, A. Russo, C. Ortega, C. Porta, S. Galluzzo, G. Armento, N. La Verde, C. Caroti, I. Treilleux, A. Ruggiero, G. Perrone, R. Addeo, P. Clezardin, A. O. Muda, and G. Tonini. 2011. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS ONE 6:e19234.
30. Sekine-Osajima, Y., N. Sakamoto, M. Nakagawa, Y. Itsui, M. Tasaka, Y. Nishimura-Sakurai, C. H. Chen, G. Suda, K. Mishima, Y. Onuki, M. Yamamoto, S. Maekawa, N. Enomoto, T. Kanai, K. Tsuchiya, and M. Watanabe. 2009. Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication. Hepatol. Res. 39:60-69.
31. Shiotani, A., M. Takami, K. Itoh, Y. Shibasaki, and T. Sasaki. 2002. Regulation of osteoclast differentiation and function by receptor activator of NF-κB ligand and osteoprotegerin. Anat. Rec. 268:137-146.
32. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H. L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T. M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, and W. J. Boyle. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
33. Suda, T., I. Nakamura, E. Jimi, and N. Takahashi. 1997. Regulation of osteoclast function. J. Bone Miner. Res. 12:869-879.
34. Vesely, P., A. Boyde, and S. J. Jones. 1992. Behaviour of osteoclasts in vitro: Contact behaviour of osteoclasts with osteoblast-like cells and networking of osteoclasts for 3D orientation. J. Anat. 181:277-291.
35. Wang, Y., J. F. Hou, and Z. L. Zhou. 2008. Chicken receptor activator of nuclear factor-kappaB ligand induces formation of chicken osteoclasts from bone marrow cells and also directly activates mature osteoclasts. Poult. Sci. 87:2344-2349.
36. Xing, L., and B. F. Boyce. 2005. Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem. Biophys. Res. Commun. 328:709-720.
37. Yip, K. H., M. H. Zheng, H. T. Feng, J. H. Steer, D. A. Joyce, and J. Xu. 2004. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappa B activity. J. Bone Miner. Res. 19:1905-1916.
38. 2+-sensing receptor agonists activate nonselective cation conductance in freshly isolated rat osteoclasts. Bone 22:495-501.